COMMUNIQUÉS West-GlobeNewswire

Cube Biotech and X-Chem Partner to Enable DNA-encoded Library Screening of NativeMP™-stabilized Membrane Proteins
21/08/2025
MONHEIM, Germany and Waltham, Mass. , Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cube Biotech, a pioneer in membrane protein stabilization and purification, and X-Chem, the global leader in DNA-Encoded Library (DEL) technology [...]
Sienna Announces Completion of $175 Million Offering of 4.112% Series E Senior Unsecured Debentures
21/08/2025
NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) [...]
Quoin Pharmaceuticals’ NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome
21/08/2025
ASHBURN, Va., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
581 100 $ récoltés pour de l’équipement d’imagerie médicale à la fine pointe lors du Tournoi de golf annuel de l’Hôpital Shriners du Canada
21/08/2025
MONTRÉAL, 21 août 2025 (GLOBE NEWSWIRE) -- Le 14e tournoi de golf annuel de l’Hôpital Shriners pour enfants Canada, qui s’est tenu le 7 août 2025 au Summerlea Golf and Country Club , a réuni 252 golfeurs, 47 bénévoles, [...]
Shriners Hospitals for Children Canada golf tournament raises $581,100 for state-of-the-art medical imaging equipment
21/08/2025
MONTREAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The 14th annual Shriners Hospitals for Children Canada Golf Tournament, held on August 7, 2025 at Summerlea Golf and Country Club , united 252 golfers, 47 volunteers, generous [...]
ICU Medical to Participate in Upcoming Investor Conferences
21/08/2025
SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following [...]
60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
21/08/2025
WASHINGTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne [...]
AMPS to Spotlight ClaimInsight at CAHP 2025, Delivering a Smarter Future for Payment Integrity in California
21/08/2025
PHOENIX, Aug. 21, 2025 (GLOBE NEWSWIRE) -- As the California healthcare system faces unprecedented financial strain and legislative complexity, Advanced Medical Pricing Solutions (AMPS) will bring a powerful cost [...]
Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)
21/08/2025
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for atumelnant, a novel [...]
Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™
21/08/2025
GAITHERSBURG, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- As opioid emergencies continue to be the leading cause of accidental death in the United States, 1 Emergent BioSolutions (NYSE: EBS) is teaming up with Voices for [...]
Parexel Appoints Biotech Business Head Jim Anthony to Expanded Role as Chief Commercial Officer and President, Parexel Biotech
21/08/2025
Strategic leadership appointment strengthens company’s commercial approach to drive continued growth and deliver long-term value DURHAM, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical [...]
Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform
21/08/2025
-- First in the FemSperm family, the Setup Kit enables gynecologists to offer FemaSeed directly, expanding access ahead of IVF and driving revenue growth -- ATLANTA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. ( [...]
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
21/08/2025
Milestones underscore Resmed’s leadership and commitment to delivering life-changing health technology that people love SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health [...]
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
21/08/2025
Tom Equels, CEO of AIM ImmunoTech provides a corporate update and reiterates focus on driving Ampligen forward in pancreatic cancer OCALA, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM [...]
Trinity Biotech Appoints Paul Tivnan as Non-Executive Director
21/08/2025
DUBLIN, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today [...]
KFSHRC Saves Saudi 7-Year-Old Through Cross-Border Heart Transplant with UAE Donor Organ
21/08/2025
RIYADH, Saudi Arabia, Aug. 21, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed a life-saving heart transplant on a 7-year-old Saudi child using [...]
InnoCare Announces First Patient Dosed in the Registrational Trial of BCL2 Inhibitor Mesutoclax for Treatment of BTKi-treated MCL Patients in China
21/08/2025
BEIJING, Aug. 21, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
U.S. Oral Surgery Management Named to Inc. 5000 List of America’s Fastest Growing Companies
21/08/2025
IRVING, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Inc. has named U.S. Oral Surgery Management ( USOSM ) to the 2025 Inc. 5000, an annual list that ranks the fastest growing private companies in the U.S., according to [...]
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
21/08/2025
– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The Company is on track to [...]

Pages